Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)

Market Cap	54.15B -10.0%
Revenue (ttm)	288.08B +4.4%
Net Income	5.81B +33.8%
EPS	1.56 +33.6%
Shares Out	3.71B
PE Ratio	10.35
Forward PE	11.78
Dividend	0.47 (2.87%)
Ex-Dividend Date	Jan 5, 2026

Volume	7,064,296
Open	16.40
Previous Close	16.39
Day's Range	16.15 - 16.41
52-Week Range	16.09 - 19.68
Beta	0.25
Analysts	Buy
Price Target	20.56 (+27.07%)
Earnings Date	Apr 30, 2026

About SHA:601607

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 49,608
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 601607

Financial Performance

In 2025, SHA:601607's revenue was 283.58 billion, an increase of 3.03% compared to the previous year's 275.25 billion. Earnings were 5.72 billion, an increase of 25.74%.